Loading...
Hologic, Inc.
0J5Q.L•LSE
Healthcare
Medical - Equipment & Services
£66.27
£-0.50(-0.75%)
Hologic, Inc. (0J5Q.L) Financial Performance & Income Statement Overview
Review Hologic, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.00%
↓ 0.002%
Operating Income Growth
45.15%
↑ 45.15%
Net Income Growth
73.14%
↑ 73.14%
Operating Cash Flow Growth
22.26%
↑ 22.26%
Operating Margin
23.70%
↑ 23.70%
Gross Margin
57.17%
↑ 57.17%
Net Profit Margin
18.42%
↑ 18.42%
ROE
15.11%
↑ 15.11%
ROIC
12.39%
↑ 12.39%
Hologic, Inc. (0J5Q.L) Income Statement & Financial Overview
Review Hologic, Inc.'s (0J5Q.L) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $1.005B | $1.02B | $987.90M | $1.01B |
| Cost of Revenue | $623.30M | $446.00M | $430.30M | $443.10M |
| Gross Profit | $382.00M | $575.80M | $557.60M | $568.30M |
| Gross Profit Ratio | $0.38 | $0.56 | $0.56 | $0.56 |
| R&D Expenses | $61.50M | $60.30M | $67.30M | $64.10M |
| SG&A Expenses | $274.10M | $281.80M | $249.20M | $240.30M |
| Operating Expenses | $384.30M | $350.70M | $327.60M | $304.40M |
| Total Costs & Expenses | $1.01B | $792.00M | $757.80M | $747.50M |
| Interest Income | $14.90M | $24.20M | $28.40M | $28.40M |
| Interest Expense | $29.10M | $30.50M | $31.90M | $31.90M |
| Depreciation & Amortization | $48.20M | $74.00M | $74.60M | $72.30M |
| EBITDA | -$7.00M | $352.00M | $328.10M | $344.90M |
| EBITDA Ratio | -$0.007 | $0.34 | $0.33 | $0.34 |
| Operating Income | -$7.00M | $229.80M | $230.10M | $263.90M |
| Operating Income Ratio | -$0.007 | $0.22 | $0.23 | $0.26 |
| Other Income/Expenses (Net) | -$21.50M | $17.70M | -$8.50M | -$23.20M |
| Income Before Tax | -$28.50M | $247.50M | $221.60M | $240.70M |
| Income Before Tax Ratio | -$0.03 | $0.24 | $0.22 | $0.24 |
| Income Tax Expense | -$11.10M | $46.50M | $43.00M | $46.20M |
| Net Income | -$17.40M | $201.00M | $178.60M | $194.50M |
| Net Income Ratio | -$0.02 | $0.20 | $0.18 | $0.19 |
| EPS | -$0.08 | $0.87 | $0.76 | $0.83 |
| Diluted EPS | -$0.08 | $0.87 | $0.76 | $0.82 |
| Weighted Avg Shares Outstanding | $225.77M | $230.28M | $233.77M | $234.60M |
| Weighted Avg Shares Outstanding (Diluted) | $225.77M | $232.11M | $235.97M | $236.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan